Positive allosteric modulation of alpha 7 nicotinic acetylcholine receptors enhances recognition memory and cognitive flexibility in rats

Eur Neuropsychopharmacol. 2015 Aug;25(8):1300-13. doi: 10.1016/j.euroneuro.2015.04.018. Epub 2015 Apr 30.

Abstract

A wide body of preclinical and clinical data suggests that alpha 7 nicotinic acetylcholine receptors (α7-nAChRs) may represent useful targets for cognitive improvement in schizophrenia and Alzheimer׳s disease. A promising recent approach is based on the use of positive allosteric modulators (PAMs) of α7-nAChRs due to their several advantages over the direct agonists. Nevertheless, the behavioural effects of this class of compounds, particularly with regard to higher-order cognitive functions, have not been broadly characterised. The aim of the present study was to evaluate the procognitive efficacies of type I and type II α7-nAChRs PAMs, N-(4-chlorophenyl)-[[(4-chlorophenyl)amino]methylene]-3-methyl-5-isoxazoleacet-amide (CCMI) and N-(5-Chloro-2,4-dimethoxyphenyl)-N'-(5-methyl-3-isoxazolyl)urea (PNU-120596) in the novel object recognition task (NORT), attentional set-shifting task (ASST) and five-choice serial reaction time task (5-CSRTT) in rats. Additionally, the effects of galantamine, an acetylcholinesterase inhibitor that also allosterically modulates nAChRs, were assessed. We report that CCMI (0.3-3mg/kg), PNU-120596 (0.3-3mg/kg) and galantamine (1-3mg/kg) attenuated the delay-induced impairment in NORT performance and facilitated cognitive flexibility in the ASST. Methyllycaconitine (3mg/kg) blocked the actions of CCMI, PNU-120596 and galantamine in the NORT and ASST, suggesting that the procognitive effects of these compounds are α7-nAChRs-dependent. However, none of the compounds tested affected the rats' attentional performance in the 5-CSRTT. The present findings confirm and extend the observations indicating that the positive allosteric modulation of α7-nAChRs enhances recognition memory and cognitive flexibility in preclinical tasks. Therefore, the present study supports the utility of α7-nAChRs PAMs as a potential cognitive enhancing therapy.

Keywords: Alpha 7 nicotinic acetylcholine receptor; Attention; Galantamine; Positive allosteric modulators; Recognition memory; Set-shifting.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allosteric Regulation
  • Animals
  • Attention / drug effects
  • Attention / physiology
  • Cholinergic Agents / pharmacology
  • Cognition / drug effects
  • Cognition / physiology*
  • Executive Function / drug effects
  • Executive Function / physiology
  • Galantamine / pharmacology
  • Isoxazoles / pharmacology
  • Male
  • Motor Activity / drug effects
  • Motor Activity / physiology
  • Phenylurea Compounds / pharmacology
  • Rats, Sprague-Dawley
  • Recognition, Psychology / drug effects
  • Recognition, Psychology / physiology*
  • alpha7 Nicotinic Acetylcholine Receptor / metabolism*

Substances

  • (N-(4-chlorophenyl))-alpha-((4-chlorophenyl)-aminomethylene)-3-methyl-5-isoxazoleacet-amide
  • 1-(5-chloro-2,4-dimethoxyphenyl)-3-(5-methylisoxazol-3-yl)urea
  • Cholinergic Agents
  • Isoxazoles
  • Phenylurea Compounds
  • alpha7 Nicotinic Acetylcholine Receptor
  • Galantamine